Your browser doesn't support javascript.
loading
Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria.
Wang, Jinjin; Mu, Mingchun; Zhu, Jinbing; Yang, Jinrong; Tao, Yali; Chen, Yuhui; Hu, Qian; Zhou, Hui; Zhao, Ailin; Niu, Ting.
Afiliação
  • Wang J; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Mu M; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhu J; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Yang J; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Tao Y; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Chen Y; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Hu Q; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhou H; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhao A; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. irenez20@outlook.com.
  • Niu T; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. niuting@wchscu.cn.
Ann Hematol ; 2024 Jul 03.
Article em En | MEDLINE | ID: mdl-38958702
ABSTRACT
This study aims to analyze the risk factors for the development of multidrug-resistant (MDR) and carbapenem-resistant (CR) bacteria bloodstream infection (BSI) in a patient with acute leukemia (AL) and the mortality in gram-negative bacteria (GNB) BSI. This is a retrospective study conducted at West China Hospital of Sichuan University, which included patients diagnosed with AL and concomitant GNB BSI from 2016 to 2021. A total of 206 patients with GNB BSI in AL were included. The 30-day mortality rate for all patients was 26.2%, with rates of 25.8% for those with MDR GNB BSI and 59.1% for those with CR GNB BSI. Univariate and multivariate analyses revealed that exposure to quinolones (Odds ratio (OR) = 3.111, 95% confidence interval (95%CI) 1.623-5.964, p = 0.001) within the preceding 30 days was an independent risk factor for MDR GNB BSI, while placement of urinary catheter (OR = 6.311, 95%CI 2.478-16.073, p < 0.001) and exposure to cephalosporins (OR = 2.340, 95%CI 1.090-5.025, p = 0.029) and carbapenems (OR = 2.558, 95%CI 1.190-5.497, p = 0.016) within the preceding 30 days were independently associated with CR GNB BSI. Additionally, CR GNB BSI (OR = 2.960, 95% CI 1.016-8.624, p = 0.047), relapsed/refractory AL (OR = 3.035, 95% CI 1.265-7.354, p = 0.013), septic shock (OR = 5.108, 95% CI 1.794-14.547, p = 0.002), platelets < 30 × 109/L before BSI (OR = 7.785, 95% CI 2.055-29.492, p = 0.003), and inappropriate empiric antibiotic therapy (OR = 3.140, 95% CI 1.171-8.417, p = 0.023) were independent risk factors for 30-day mortality in AL patients with GNB BSI. Prior antibiotic exposure was a significant factor in the occurrence of MDR GNB BSI and CR GNB BSI. CR GNB BSI increased the risk of mortality in AL patients with GNB BSI.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article